Hot Articles

Is Tellurian (TELL) Stock Worth To Buy?

Tellurian (NASDAQ: TELL) stock recorded a new high this year in early this month. The reason the stock was boosted is that the company made exceptional progress in its natural gas exports in recent month.
InvestReader Editor - 6 hours ago

Is Evofem Biosciences (EVFM) Stock Worth To Buy?

Evofem Biosciences (NASDAQ: EVFM) stock rose slightly in recent two weeks. Although the company offered 50 million shares of its common stock in the middle of last month, which caused its stock price to briefly fall, the net proceeds from the offering will be used for the continuation of full commercialization activities related to Phexxi.
InvestReader Editor - June 18, 2021

Is Electrameccanica Vehicles Corp (SOLO) Stock Worth Buying?

Electrameccanica Vehicles Corp (SOLO) stock was up by 42% since the company released its financial results for the first quarter of 2021 on May 13. The company said in the release that its flagship vehicles, called the SOLO, are now sold in ​a total of twenty retail locations throughout ten metropolitan areas in five western states.
InvestReader Editor - June 17, 2021

Is Fisker (FSR) Stock Worth To Buy?

Fisker (NYSE: FSR) stock continued to rise over the past month. On May 13, the company announced that it has signed binding agreement with Foxconn for co-investment into development and U.S. production launch of Project PEAR in Q4 2023.
InvestReader Editor - June 16, 2021

Is Atossa Therapeutics (ATOS) Stock Worth To Buy?

Atossa Therapeutics (NASDAQ: ATOS) stock recorded a new high for the year a few days ago. In fact, the stock continued to grow since the company released its first quarter 2021 financial results on May 14th. The reason investors were so excited is the company has made great progress on its two key development programs.
InvestReader Editor - June 15, 2021

Is Senseonics Holdings (SENS) Stock Worth To Buy?

Senseonics Holdings (NYSEAMERICAN: SENS) stock was up by 132% since the company released its financial results for the first quarter of 2021 on May 13. The company's total revenue for the quarter was $2.85 million, while this number was only $0.04 million in the same period last year.
InvestReader Editor - June 15, 2021

Is CytRx Corporation (CYTR) Stock Worth Buying?

CytRx Corporation (OTCMKTS: CYTR) stock soared by 154% since the company reported its results for the first quarter of 2021 on May 13. CytRx also highlighted developments pertaining to its agreements with its several partners in this release, which brought some confidence to investors.
InvestReader Editor - June 14, 2021

Is Aptinyx (APTX) Stock Worth To Buy?

Aptinyx (NASDAQ: APTX) stock soared by 34% in the past week without any headlines which were made by the company in recent times. So, is there some reasons for the stock to attract investors?
InvestReader Editor - June 14, 2021

Is Northwest Biotherapeutics (NWBO) Stock Worth To Buy?

Northwest Biotherapeutics (OTCMKTS: NWBO) stock experienced a short rise and fall process in the middle of last month. Although the stock fell by 2.5% so far this year, it is trying to recover.
InvestReader Editor - June 13, 2021

Is Cassava Sciences (SAVA) Stock Worth Buying?

Cassava Sciences (NASDAQ: SAVA) stock soared by 104% over the past month. The reason is that simufilam, the company's lead drug candidate for the treatment of Alzheimer’s disease, which will come into Phase 3 studies in the second half of this year.
InvestReader Editor - June 12, 2021

Is Novan (NOVN) Stock Worth To Buy?

Novan (NASDAQ: NOVN) stock soared after the market opened today. The reason investors were so excited is that the company announced positive topline efficacy and safety results for the B-SIMPLE4 pivotal Phase 3 clinical study of SB206 today.
InvestReader Editor - June 11, 2021

Is Abeona Therapeutics (ABEO) Stock Worth To Buy?

Abeona Therapeutics (NASDAQ: ABEO) stock rebounded slightly in recent times. The reason is that the company's clinical program, EB-101, has entered the phrase 3 study.
InvestReader Editor - June 10, 2021

Why Precipio (PRPO) Stock Worth To Buy?

Precipio (NASDAQ: PRPO) stock was up by 99% year to date. The company announced on May 3 that it has successfully launched its COVID-19 rapid antibody test product on Amazon.com's business platform, which directly pushed its stock prices to higher levels.
InvestReader Editor - June 09, 2021

Is MICT Inc (MICT) Stock Worth To Buy?

MICT Inc (NASDAQ: MICT) stock was up sharply in the past month. The reason that investors were so excited is the company achieved $8.9 million in revenue for the first quarter of 2021, and the number was zero in the year-ago period.
InvestReader Editor - June 08, 2021

Is Remark Holdings (MARK) Stock Worth Buying?

Remark Holdings (NASDAQ: MARK) stock did not continue to fall since the company released its results for the fist quarter of 2021 on May 17. Although the company's net loss was $5.5 million in the quarter, its revenue had an increase of 1000% YoY to $4.4 million.
InvestReader Editor - June 07, 2021

Will MGM Resorts International (MGM) Stock Continue To Hit New High?

MGM Resorts International (NYSE: MGM) stock just recorded a new high within a year, and had a rise of 44% so far this year.
InvestReader Editor - June 06, 2021

How To Value Castor Maritime (CTRM) Stock After Reported Its Results For The First Quarter?

Castor Maritime (NASDAQ: CTRM) stock has been falling slightly in the past two months, but this situation might reverse after the company released its results for the first quarter of 2021 on June 3.
InvestReader Editor - June 05, 2021

Will Microvision (MVIS) Stock Continue To Rally?

Microvision (NASDAQ: MVIS) stock received a lot of attention from retail investors in recent two weeks, and it had an increase of 46% in this period.
InvestReader Editor - June 05, 2021

Is Sorrento Therapeutics (SRNE) Stock Worth To Buy?

Sorrento Therapeutics (NASDAQ: SRNE) stock began to rebound slightly in recent times. The company recently released two pieces of news which caused attention from investors.
InvestReader Editor - June 05, 2021

Is Humbl (HMBL) Stock Worth Buying In June?

Humbl (OTCMKTS: HMBL) stock tanked by 80% since it recorded an all-time high in February, but it still had an increase of 132% so far this year.
InvestReader Editor - June 04, 2021

Will Torchlight Energy Resources (TRCH) Stock Climb To $4 Again?

Torchlight Energy Resources (NASDAQ: TRCH) stock came to nearly $3 per share recently. The company's stockholders will vote at the special meeting to be held on June 11, 2021 on its business combination transaction with Metamaterial.
InvestReader Editor - June 03, 2021

Is AMC Entertainment Holdings (AMC) Stock Worth To Buy Now?

AMC Entertainment Holdings (NYSE: AMC) stock rose by 208% in the past month. This is crazy and it continues to rise.
InvestReader Editor - June 01, 2021

Is XpresSpa Group (XSPA) Stock Worth To Buy?

XpresSpa Group (NASDAQ: XSPA) stock rose by only 17% so far this year, but this is a penny stock that could be worth watching closely.
InvestReader Editor - May 29, 2021

Will Ashford Hospitality Trust (AHT) Stock Continue To Rise?

Ashford Hospitality Trust (NYSE: AHT) stock just reached its highest point since this year, despite there was no direct positive news from the company recently.
InvestReader Editor - May 28, 2021

Will T2 Biosystems (TTOO) Stock Continue To Rebound In The Next Few Months?

T2 Biosystems (NASDAQ: TTOO) stock recently began to rebound slightly, but still down by 7% so far this year.
InvestReader Editor - May 27, 2021

Will Cinedigm (CIDM) Stock Hit Two Dollars This Year?

Cinedigm (NASDAQ: CIDM) stock recently began to rise to its current value of $1.47 per share, and the next target for the stock, will be two dollars.
InvestReader Editor - May 26, 2021

Is Ault Global Holdings (DPW) Stock Worth Buying?

Ault Global Holdings (NYSEAMERICAN: DPW) stock fell by 37% so far this year, but it rebounded slightly after the company released its financial results for the first quarter of 2021 on May 24.
InvestReader Editor - May 26, 2021

Is Comstock Mining (LODE) Stock Worth Buying?

Comstock Mining (NYSEAMERICAN: LODE) stock began to rebound slightly since the company reported its first quarter 2021 results on May 12. The stock has gained an increase of 250% so far this year.
InvestReader Editor - May 25, 2021

Is Onconova Therapeutics (ONTX) Stock Worth Buying After Announcing A Reverse Stock Split?

Onconova Therapeutics (NASDAQ: ONTX) stock has experienced a roller coaster ride in recent two weeks. Although the company just announced a reverse stock split of its common stock, investors are still focusing on its clinical trial programs in its pipeline.
InvestReader Editor - May 25, 2021

Is It Time To Buy Tellurian (TELL) Stock?

Tellurian (NASDAQ: TELL) stock started to rebound in recent weeks. The stock has risen by 106% so far this year. The demand from global markets for liquefied natural gas is growing, which raised much interest from investors to the company.
InvestReader Editor - May 24, 2021